Sublime

Neil Mehta’s Greenoaks: The $15 Billion Silent Fund Betting on S&P 500 Caliber Founders When Neil Mehta left D.E. Shaw at 27, he launched Greenoaks Capital with no brand, no firm history, and just one goal: investing big in businesses that could reshape the world. Within months, he put 40% o... See more

This book is by an FDA-sympathetic voice, but much of the book (inadvertently?) illustrates the sheer ruthlessness of the regulatory state. Intimidation of biotech executives, retaliating for criticism, political maneuvering…it’s all there. https://t.co/FgbncFc957... See more